+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Cosmetic Surgery and Procedure Market Size, Share & Industry Trends Analysis Report By Procedure Type, By Non-invasive Type, By Invasive Type, By Country and Growth Forecast, 2021-2027

  • PDF Icon

    Report

  • 80 Pages
  • March 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5590474
The North America Cosmetic Surgery And Procedure Market is expected to witness market growth of 9.0% CAGR during the forecast period (2021 2027).

Cosmetic facial plastic surgery processes appear to function in the marketplace as luxury products, with just an upward-sloping demand curve. It is more traditional goods, where demand typically reduces as prices rise. Economic methods appear to be capable of assessing cosmetic procedure trends. However, such techniques are formed on appropriate economic theory.

Excess skin and fat are excluded from the abdomen, and the underlying abdomen muscle fibers are stiffened. The navel is usually needed to be relocated. Incisions are usually made along the 'bikini line' to minimize scarring visibility. This method is conducted under anesthesia. Numbness and inconvenient cramping are common symptoms of surgery that can last for months. Infection and the creation of fluid pockets are two complications.

Facial fillers are injected temporarily to soften wrinkles. Infusion of facial padding is usually performed as an outpatient surgery under local anesthetics. The procedure can take over an hour. The implications could be long-term. Moreover, achieving the desired results usually necessitates more than one meeting of infusions, along with overstocking the location to recompense again for the body's absorption of nutrients of the fat.

As per the American Society of Plastic Surgeons, 13,281,235 cosmetic nonsurgical processes were performed in the United States in 2020, with botulinum toxin procedures accounting for 4,401,536 along with Non-invasive body fat removal was among the top 5 non-invasive operations in the United States in 2020, according to the Aesthetic Society (US), with 140,314 procedures completed.

In the United States, there is much more rivalry, with several companies launching many products, for example, Allergan got approval from the US FDA in July 2021 to extend the label of BOTOX that included eight new muscles for treating upper limb stiffness in adults. Additionally, elbow and forearm muscles are one of the new muscles to be treated.

The usage of botulinum toxins in aesthetic medicine has increased. The cosmetic reasons approved by the US FDA for Botox injections are frowning wrinkles, crow's feet, and horizontal forehead lines. They offer accurate results with low side effects and are related to higher patient satisfaction as the substance's use expands. As a result, the segment is predicted to grow rapidly over the world.

The US market dominated the North America Cosmetic Surgery And Procedure Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $27,013.9 million by 2027. The Canada market is anticipated to grow at a CAGR of 11.5% during (2021 - 2027). Additionally, The Mexico market is expected to display a CAGR of 10.5% during (2021 - 2027).

Based on Procedure Type, the market is segmented into Non-invasive, and Invasive. Based on Non-invasive Type, the market is segmented into Botox Injections, Laser Hair Removal, Soft Tissue Fillers, Chemical Peel, Microdermabrasion, and Others. Based on Invasive Type, the market is segmented into Breast Augmentation, Liposuction, Nose Reshaping, Tummy Tuck, Eyelid Surgery, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Evolus, Inc., Revance Therapeutics, Inc., Cynosure, LLC, Alma Lasers Ltd., Candela Medical Corporation, Bausch Health Companies, Inc., Lumenis Ltd., Galderma S.A., and AbbVie, Inc.

Scope of the Study


Market Segments Covered in the Report:


By Procedure Type

  • Non-invasive
  • Botox Injections
  • Laser Hair Removal
  • Soft Tissue Fillers
  • Chemical Peel
  • Microdermabrasion
  • Others
  • Invasive
  • Breast Augmentation
  • Liposuction
  • Nose Reshaping
  • Tummy Tuck
  • Eyelid Surgery
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players


List of Companies Profiled in the Report:

  • Evolus, Inc.
  • Revance Therapeutics, Inc.
  • Cynosure, LLC
  • Alma Lasers Ltd.
  • Candela Medical Corporation
  • Bausch Health Companies, Inc.
  • Lumenis Ltd.
  • Galderma S.A.
  • AbbVie, Inc.

Unique Offerings from the publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cosmetic Surgery And Procedure Market, by Procedure Type
1.4.2 North America Cosmetic Surgery And Procedure Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Publisher Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
Chapter 4. North America Cosmetic Surgery And Procedure Market by Procedure Type
4.1 North America Non-invasive Market by Country
4.2 North America Cosmetic Surgery And Procedure Market by Non-invasive Type
4.2.1 North America Botox Injections Market by Country
4.2.2 North America Laser Hair Removal Market by Country
4.2.3 North America Soft Tissue Fillers Market by Country
4.2.4 North America Chemical Peel Market by Country
4.2.5 North America Microdermabrasion Market by Country
4.2.6 North America Others Market by Country
4.3 North America Invasive Market by Country
4.4 North America Cosmetic Surgery And Procedure Market by Invasive Type
4.4.1 North America Breast Augmentation Market by Country
4.4.2 North America Liposuction Market by Country
4.4.3 North America Nose Reshaping Market by Country
4.4.4 North America Tummy Tuck Market by Country
4.4.5 North America Eyelid Surgery Market by Country
4.4.6 North America Others Market by Country
Chapter 5. North America Cosmetic Surgery And Procedure Market by Country
5.1 US Cosmetic Surgery And Procedure Market
5.1.1 US Cosmetic Surgery And Procedure Market by Procedure Type
5.1.1.1 US Cosmetic Surgery And Procedure Market by Non-invasive Type
5.1.1.2 US Cosmetic Surgery And Procedure Market by Invasive Type
5.2 Canada Cosmetic Surgery And Procedure Market
5.2.1 Canada Cosmetic Surgery And Procedure Market by Procedure Type
5.2.1.1 Canada Cosmetic Surgery And Procedure Market by Non-invasive Type
5.2.1.2 Canada Cosmetic Surgery And Procedure Market by Invasive Type
5.3 Mexico Cosmetic Surgery And Procedure Market
5.3.1 Mexico Cosmetic Surgery And Procedure Market by Procedure Type
5.3.1.1 Mexico Cosmetic Surgery And Procedure Market by Non-invasive Type
5.3.1.2 Mexico Cosmetic Surgery And Procedure Market by Invasive Type
5.4 Rest of North America Cosmetic Surgery And Procedure Market
5.4.1 Rest of North America Cosmetic Surgery And Procedure Market by Procedure Type
5.4.1.1 Rest of North America Cosmetic Surgery And Procedure Market by Non-invasive Type
5.4.1.2 Rest of North America Cosmetic Surgery And Procedure Market by Invasive Type
Chapter 6. Company Profiles
6.1 Evolus, Inc. (Alphaeon Corporation)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expenses
6.2 Revance Therapeutics, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Research & Development Expenses
6.3 Cynosure, LLC
6.3.1 Company Overview
6.3.2 Recent strategies and developments:
6.3.2.1 Acquisition and Mergers:
6.3.2.2 Geographical Expansions:
6.4 Alma Lasers Ltd. (Sisram Medical Ltd.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches and Product Expansions:
6.4.5.2 Approvals and Trials:
6.5 Candela Medical Corporation (Syneron Medical Ltd.)
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Acquisition and Mergers:
6.6 Bausch Health Companies, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Lumenis Ltd.
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Product Launches and Product Expansions:
6.8 Galderma S.A.
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Partnerships, Collaborations, and Agreements:
6.8.2.2 Product Launches and Product Expansions:
6.8.2.3 Acquisition and Mergers:
6.9 AbbVie, Inc. (Allergan PLC)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.9.5 Recent strategies and developments:
6.9.5.1 Approvals and Trials:
6.9.5.2 Acquisition and Mergers:

Companies Mentioned

  • Evolus, Inc.
  • Revance Therapeutics, Inc.
  • Cynosure, LLC
  • Alma Lasers Ltd.
  • Candela Medical Corporation
  • Bausch Health Companies, Inc.
  • Lumenis Ltd.
  • Galderma S.A.
  • AbbVie, Inc.

Methodology

Loading
LOADING...